Optimization of HPLC method using central composite design for estimation of Torsemide and Eplerenone in tablet dosage form
DOI:
https://doi.org/10.1590/s2175-97902022e20219%20%20Keywords:
Torsemide, Eplerenone, Quality by Design, RP-HPLC method, TabletAbstract
A simple, precise, accurate and robust high performance liquid chromatographic method has been developed for simultaneous estimation of Torsemide and Eplerenone in tablet dosage form. Design of experiment was applied for multivariate optimization of the experimental conditions of RP-HPLC method. A Central composite design was used to study the response surface methodology and to analyse in detail the effects of these independent factors on responses. Total eleven experiments along with 3 center points were performed. Two factors were selected to design the matrix, one factor is variation in ratio of Acetonitrile and the second factor is flow rate (mL/min). Optimization in chromatographic conditions was achieved by applying Central composite design. The optimized and predicted data from contour diagram comprised mobile phase (acetonitrile, water and methanol in the ratio of 50: 30: 20 v/v/v respectively), at a flow rate of 1.0 ml/min and at ambient column temperature. Using these optimum conditions baseline separation of both drugs with good resolution and run time of less than 5 minutes were achieved. The optimized assay conditions were validated as per the ICH guidelines (2005). Hence, the results showed that the Quality by design approach could successfully optimize RP-HPLC method for simultaneous estimation of Torsemide and Eplerenone.
Downloads
References
Akesolo U, Gonzalez L, Jimenez RM, Alonso RM. Multivariate optimisation of a cyclodextrin-assisted-capillary zone electrophoretic method for the separation of torsemide and its metabolites. J Chromatogr A. 2003;990(1-2):271-9.
Awotwe-Otoo D, Agarabi C, Faustino PJ, Habib MJ, Lee S, Khan MA, Shah RB. Application of quality by design elements for the development and optimization of an analytical method for protamine sulfate. J Pharm Biomed Anal. 2012;62:61-7.
Bagade SB, Patil SK. Spectrophotometric Estimation of Torsemide in Tablet Dosage Form Using Chemical Derivatization Technique. Int J Pharm Qual Assur. 2010;2(1):52-5.
Bhadja SA, Chhalotiya UK, Shah DA, Mehta FA, Bhatt KK. Simultaneous estimation of torsemide and amiloride hydrochloride in their pharmaceutical dosage form by dual wavelength UV spectroscopic method. Adv J Pharm Life Sci Res. 2014a;2(1):21-8.
Bhadja S, Shah D, Mehta F, Bhatt K. Simultaneous estimation of amiloride hydrochloride and torsemide in their combined dosageformsbyhigh-performancethin-layerchromatography. J Planar Chromatogr - Mod TLC. 2014b;27(4):294-298. https://doi.org/10.1556/JPC.27.2014.4.10.
» https://doi.org/https://doi.org/10.1556/JPC.27.2014.4.10
Bhalodiya KJ, Modiya D, Faldu S. Analytical Method Development and Validation for Simultaneous Estimation of Amiloride and Torsemide in their Combined Pharmaceutical Dosage form by RP-HPLC Method. PharmaTutor. 2014;2(7):135-41.
Bihola U, Prajapati P, Agrawal YK. HPLC - Quality by Design Approach for Simultaneous Detection of Torsemide, Spironolactone and Their Degradant Impurities. Pharm Technol Hosp Pharm. 2018;3(3):123-34.
Bukwanik K, Filist M, Rudzki PJ. Environmentally friendly LC/MS determination of Eplerenone in human plasma. Acta Pol Pharm. 2016;73(6):1487-93.
Dawud ER, Shakya AK. HPLC-PDA analysis of ACE-inhibitors hydrochlorothiazide and indapamide utilizing design of experiments. Arab J Chem. 2014 [In press].
Deshpande PB, Gandhi SV, Gaikwad NV, Khandagle KS. A simple and sensitive RP-HPLC method for simultaneous estimation of torsemide and spironolactone in combined tablet dosage form. Acta Chromatogr. 2012;24(1):15-22. https://doi.org/10.1556/AChrom.24.2012.1.2.
» https://doi.org/https://doi.org/10.1556/AChrom.24.2012.1.2
Dubey N, Patil G, Jain DK, Chaturvedi S. Simultaneous estimation of Torsemide and Spiranlactone in combined dosage form using Reverse phase Liquid chromatography. Int J Biomed Pharm Sci. 2012;7(1):38-41.
Fernández M, Alonso RM, Jiménez RM, Legorburu MJ. Differential-pulse adsorptive stripping voltammetry of the diuretic torasemide at a hanging mercury drop electrode. Analyst. 1994;119(2):319-22.
Ficarra R, Calabro ML, Cutroneo P, Tommasini S, Melardi S, Semreen M, et al. Validation of a LC method for the analysis of oxaliplatin in a pharmaceutical formulation using an experimental design. J Pharm Biomed Anal . 2002;29(6):1097-103.
Gaikwad NV, Deshpande PB, Gandhi SV, Khandagale KK. High performance thin layer chromatographic determination of spironolactone and torsemide in combined tablet dosage form. Res J Pharm Technol. 2010;3(4):1106-08.
Ganorkar SB, Dhumal DM, Shirkhedkar AA. Development and validation of simple RP-HPLC-PDA analytical protocol for zileuton assisted with design of experiments for robustness determination. Arab J Chem . 2017;10(2):273-82.
Ghodke AY, Poul BN, Sorde MB. Analytical method development and validation for quantitative estimation of torsemide in bulk and Pharmaceutical dosage form by RP-HPLC. Int J Pharm Chem Anal. 2014;1(1):6-11.
Golher HK, Kapse K, Singh SK. Simultaneous spectrophotometric estimation of torsemide and spironolactone in tablet dosage form. Int J Pharmtech Res. 2010;2(4):2246-50.
Gundala A, Prasad KVSRG, Koganti B. Application of quality by design approach in RPHPLC method development for simultaneous estimation of saxagliptin and dapagliflozin in tablet dosage form. Braz J Pharm Sci. 2019;55:1-13.
Hinge MA, Patel D, Patel A. Development and Validation of UV spectrophotometric method for Simultaneous estimation of Torsemide and Eplerenone in Bulk drugs and Combined dosage forms. Int J Pharm Sci Rev Res. 2019;56(2):63-7.
https://pubchem.ncbi.nlm.nih.gov/compound/torsemide, accessed on date: 10/03/2017.
» https://pubchem.ncbi.nlm.nih.gov/compound/torsemide
https://pubchem.ncbi.nlm.nih.gov/compound/Eplerenone, accessed on date: 10/03/2017.
» https://pubchem.ncbi.nlm.nih.gov/compound/Eplerenone
ICH. Q2 (R1): Guidelines on validation of analytical procedure: text and methodology. 2005. http://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Quality/Q2_R1/Step4/Q2_R1_Guideline.pdf
Indian pharmacopoeia, Government of India, ministry of health and family welfare. Volume II. 2014. 1668-1669p.
Jovic Z, Zivanovic L, Radisic M, Protic A, Malesevic M. Chemometrically Assisted Development and Validation of LC-UV and LC-MS Methods for Simultaneous Determination of Torasemide and its Impurities. J Chromatogr Sci. 2012;50(4):324-34.
Kakde R, Chaudhary N, Barsagade A, Kale D. Stability-Indicating HPTLC Method for Analysis of Torsemide in Pharmaceutical Preparations. Acta Chromatogr . 2011;23(1):145-55.
Karbhari PA, Bhoir SI, Joshi SJ. A stability indicating LC method for simultaneous determination of torsemide, spironolactone and their related substances in tablet formulation. Anal Chem Ind J. 2013;13(8):290-302.
Khan IJ, Loya P, Saraf MN. A simplified HPLC method for quantification of torsemide from human plasma and its application to a bioequivalence study. Indian J Pharm Sci. 2008;70(4):519-22.
Kranthi KK, Jhansi LB, Ganesh K. Method development and validation for the simultaneous estimation of eplerenone and torsemide using RP-HPLC. Novel Sci Int J Pharm Sci. 2018;3(2):443-49.
Krishna MV, Sankar DG. Simple Spectrophotometric Determination of Torsemide in Bulk Drug and in Formulations. E-J Chem. 2008;5(3):473-78.
Laxman R, Acharya A, Jain V, Bhardwaj S, Jain D. Development and Validation of RP-HPLC and validation of RP-HPLC and Ultraviolet spectrophotometric methods for simultaneous determination of Spiranolactone and Torsemide in pharmaceutical dosage form. Int J Res Ayurveda Pharm. 2010;1(2):459-67.
Mahajan BH, Kekar N, Shah S. Quantitative Determination of Eplerenone in Bulk drug and tablet Dosage form by TLC. Int J Pharm Life Sci. 2011;2(1):502-05.
Mohammad MT, Surya Prakash DV, Vangalapati M. Development of response surface methodology for optimization of parameters and quantitative analysis of chebulinic acid from composition of medicinal herbs by HPLC. Saudi J Biol Sci. 2019;26(7):1809-1814.
Monks K, Molnár I, Rieger HJ, Bogáti B, Szabó E. Quality by design: multidimensional exploration of the design space in high performance liquid chromatography method development for better robustness before validation. J Chromatogr A . 2012;1232:218-30.
Nooshin A, Hamid Z. Optimization of organosolv pretreatment of rice straw for enhanced biohydrogen production using Enterobacter aerogenes. Bioresour Technol. 2017;227:335-344.
Patel KG, Patel AT, Shah PA, Gandhi TR. Multivariate optimization for simultaneous determination of aspirin and simvastatin by reverse phase liquid chromatographic method using AQbD approach. Bull Fac Pharm, Cairo Univ. 2017b;55(2):293-301.
Patel KS, Bendale A, Luhar SV, Narkhede SB. Development and validation of RP-HPLC method for the simultaneous estimation of eplerenone and torsemide in pharmaceutical dosage form. J Pharm Sci Bio-Sci Res. 2016;6(3):283-90.
Patel RB, Patel BR, Patel JG, Patel VS. Stability indicating RP-HPLC method development and validation for simultaneous estimation of eplerenone and torsemide in Tablet dosage form. World J Pharm Pharm Sci. 2017a;6(5):1397-1406.
Peraman R, Bhadraya K, Reddy YP, Reddy CS, Lokesh T. Analytical quality by design approach in RP-HPLC method development for the assay of Etofenamate in dosage forms. Indian J Pharm Sci . 2015;77(6):751-7.
Rang HP, Dale MM, Ritter JM, Flower RJ. Pharmacology. 6th edition. Churchill Livingstone: 2007. 309-310p.
Rane VP, Patil KR, Sanshethi JN, Yeole RD. Stability indicating RP-HPLC Method for Analysis of Eplerenone in a pharmaceutical Dosage form. Acta Chromatogr . 2009;21(4):619-29.
Reddy KD, Sayanna K, Venkateshwarlu G. Kinetic Spectrophotometric determination of Drugs Based on Oxidation by Alkaline KmnO4 IOSR J Applied Chem. 2014;6(6):08-14.
Rollinger JM, Novák CS, Éhen ZS, Marthi K. Thermal characterization of torsemide using coupled techniques. J Therm Anal Calorim. 2003;73(2):519-526.
Sasikala M, Sayanna K, Venkateshwarlu G. Spectrophotometric Determination of Drugs by using Chloramine-T and Methyl Orange. World J Pharm Res. 2015;4(2):709-22.
Shaniya P, Hopsebah NJ, Khasim MD, Kumar AA. Dissolution method development and validation of eplerenone tablet by UV spectroscopy. Ind-Ame. J Pharm Sci. 2016;3(4):351-57.
Shailaja B, Swarna K, Afreen M, Ashok Kumar A. A rapid assay method development and validation for the estimation of eplerenone in tablets by UV spectrophotometry. Int J Pharm Pharm Sci. 2015;7(9):327-330.
Sharma S, Sharma MC, Kohli DV, Chaturvedi SC. Isocratic reverse phase HPLC estimation method of Torsemide and Spironolactone in Pharmaceutical combined dosage form. Optoelectron Adv Mat. 2010a;4(2):234-37.
Sharma MC, Sharma S, Kohli DV, Sharma AD. Validated TLC Densitometric method for the quantification of Torsemide and Spironolactone in bulk drug and in tablet dosage form. Der Pharma Chem. 2010b;2(1):121-26.
Shukla R, Bhavsar N, Pandey V, Golhani D, Jain AP. RP-HPLC Determination of Torsemide in Pharmaceutical Formulation by Liquid Chromatography. Asian J Biomed Pharm Sci. 2012;2(15):45-48.
Subramanian V, Nagappan K, Mannemala SS. Optimization and validation of a sensitive method for HPLC-PDA simultaneous determination of torasemide and spironolactone in human plasma using central composite design. Acta Chim Slov. 2015;62:633-41.
United States Pharmacopoeia 30-National Formulary 25. 2007.3385p.
Wen-juan Q, Li D, Ai-dong W, Bin G, Ye L, Chang-hong Y, Lin Y. Establishment of HPLC-ESI-MS method for the determination of Eplerenone in human plasma and its pharmacokinetics. Acta Pharm Sin. 2009;44(7):771-77.
Zaazaa HE, Abbas SS, Essam HM, El-Bardicy MG. Development and validation of stability-indicating methods for determination of torsemide. Bull Chem Soc Ethiop. 2016;30(1):13-25.
Zhang L, Wang R, Tuan Y, Zhang Z. Determination of torasemide in human plasma and its bioequivalence study by high-performance liquid chromatography with electrospray ionization tandem mass spectrometry. J Pharm Anal. 2016;6(2):95-102.
Downloads
Published
Issue
Section
License
Copyright (c) 2022 Brazilian Journal of Pharmaceutical Sciences
This work is licensed under a Creative Commons Attribution 4.0 International License.
All content of the journal, except where identified, is licensed under a Creative Commons attribution-type BY.
The on line journal has open and free access.
